Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2022, Vol. 145, No. 2

Review

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 113–121. https://doi.org/10.1159/000519769
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 122–131. https://doi.org/10.1159/000519782

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 132–143. https://doi.org/10.1159/000516588
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 144–151. https://doi.org/10.1159/000518920
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 152–159. https://doi.org/10.1159/000519292
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 160–169. https://doi.org/10.1159/000519360
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 170–175. https://doi.org/10.1159/000520439
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 176–183. https://doi.org/10.1159/000520446
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 184–192. https://doi.org/10.1159/000520638

Brief Report

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 193–200. https://doi.org/10.1159/000518744

Case Report

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 201–206. https://doi.org/10.1159/000518737
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 207–209. https://doi.org/10.1159/000518815
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 210–213. https://doi.org/10.1159/000519451
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 214–220. https://doi.org/10.1159/000520240
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 221–228. https://doi.org/10.1159/000520438

Pharma News

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (2): 229–232. https://doi.org/10.1159/000523783
Close Modal

or Create an Account

Close Modal
Close Modal